Navitoclax Plus Ruxolitinib In Jak Inhibitor-Naive Patients With Myelofibrosis: Preliminary Safety And Efficacy In A Multicenter, Open-Label Phase 2 Study
Navitoclax;Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Navitoclax Plus Ruxolitinib In Jak Inhibitor-Naive Patients With Myelofibrosis: Preliminary Safety And Efficacy In A Multicenter, Open-Label Phase 2 Study ### Output: Navitoclax;Ruxolitinib